Softbank leads $100M investment in remote monitoring startup Biofourmis
Biofourmis, a Boston-based company that makes software-based therapeutic platforms, raised $100 million in a series C round led by SoftBank’s second Vision Fund. The company currently has developed a digital therapeutic for heart failure patients with Novartis, and plans to expand into other clinical areas.